SOCS1 gene therapy (National Institute of Biomedical Innovation)

N/A

Report date: 2025/01/26 15:40:22

Base Information

Drug NameSOCS1 gene therapy (National Institute of Biomedical Innovation)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionSuppressor of cytokine signaling 1 stimulants
TargetsSuppressor of cytokine signaling 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Biomedical Innovation
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Biomedical Innovation
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A